Bio Protocol vs Open Gradient — how do they compare? Bio Protocol trades at Rp433.7 (market cap Rp983,55M, Rp163,9M 24h volume), while Open Gradient trades at Rp1,657 (market cap Rp350,91M, Rp176,63M 24h volume). The key difference: Bio Protocol is far larger — about 2.8× Open Gradient's market cap, and Bio Protocol's circulating supply is 2,3B / 3,3B BIO (69%) versus 213,8M / 1B OPG (22%) for Open Gradient. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 18 Days and Open Gradient for 5 Days on average.
| BIO | OPG | |
|---|---|---|
Market Cap | Rp983,55M | Rp350,91M |
Volume (24h) | Rp163,9M | Rp176,63M |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 213,8M / 1B OPG (22%) |
Typical Hold Time | 18 Days | 5 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp438.8 with a market cap of Rp996.68M, showing neutral technical signals overall. The token is currently testing the pivot point at Rp440, with immediate support at Rp430 and resistance at Rp454. With 69% of max supply in circulation and an average hold time of 18 days, the token exhibits moderate liquidity. Recent technical indicators show mixed signals with bearish moving averages but neutral oscillators.
Outlook remains neutral with key opportunities in potential breakout above Rp454 resistance. Major risks include low market cap vulnerability to volatility and limited fundamental developments. Investors should monitor trading volume patterns and broader crypto market sentiment for directional cues.
Open Gradient (OPG) is currently trading at Rp1,624.65 with a market cap of Rp346.34 million, exhibiting a bearish technical signal overall. The asset is in a neutral zone according to oscillators but faces strong selling pressure from moving averages. Key support lies at Rp1,603, with resistance at Rp1,677. No recent protocol updates or significant ecosystem developments have been reported.
The outlook remains cautious due to prevailing bearish momentum and limited fundamental catalysts. Key opportunities include potential rebounds from support levels, while major risks involve low liquidity, high volatility, and the absence of recent positive developments. Investors should monitor for any shifts in on-chain activity or exchange listings.
What Pluang investors did over the last 30 days
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →OPG is the native asset of Open Gradient, a protocol focused on enabling collaboration, coordination, and value exchange around AI models and AI-generated outputs. The ecosystem combines blockchain infrastructure with artificial intelligence to support decentralized participation in the development, deployment, and utilization of AI technologies.
Read more on OPG →